0078-0592 : Tasigna 150 mg Oral Capsule


NDC0078-0592
Labeler: Novartis Pharmaceuticals Corporation
Product Type: Human Prescription Drug
Drug Name:  Tasigna
Dosage Form: Oral Capsule
Application #: NDA022068
Rev. Date: 


Appearance:


Markings: NVR;BCR
Shapes:  Capsule
Colors:  Red
Size (mm): 22
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 0078-0592-51: 28 CAPSULE IN 1 BLISTER PACK (0078‑0592‑51)
  • 0078-0592-87: 4 BLISTER PACK IN 1 CARTON (0078‑0592‑87) > 28 CAPSULE IN 1 BLISTER PACK

Active Ingredients:

  • Nilotinib

Dosage Strength:

  • 150 mg

Inactive Ingredients:

  • Silicon Dioxide
  • Crospovidone
  • Lactose Monohydrate
  • Magnesium Stearate
  • Poloxamer 188
  • Gelatin
  • Ferric Oxide Red
  • Ferric Oxide Yellow
  • Titanium Dioxide

Pharmaceutical Classes:

  • Kinase Inhibitor [EPC]
  • Protein Kinase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0078-0526 Tasigna 200 mg Oral Capsule by Novartis Pharmaceuticals Corporation
  • 0078-0951 Tasigna 50 mg Oral Capsule by Novartis Pharmaceuticals Corporation

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0078-0592 QR Code

< Prev: 0078-0590Next: 0078-0594 >

Related Discussions:

tasigna
I'm trying to find out how I can obtain Tasigna for a minimal cost. It runs $10,000 a month. How can I get it cheape... 1 reply
Unexplained pains after starting Tasigna
My wife is on tasigna for over a year now and has gad some moderate heart problems first a slim heart rate 50bpm then la... 2 replies
safe acid reflux medication while taking tasigna
I am having a very difficult time with acid reflux while taking tasigna. My doctor doesn't approve any of the acid r... 1 reply
Tasigna (Nilotinib) Availability
Please help. My husband has been diagnosed with CML. He was prescribed Tasigna by his doctor. My problem is there is no ...




Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.